What is G1 Therapeutics Inc’s (GTHX) Stock Real Technical Picture?

JP Morgan raised the price target for the G1 Therapeutics Inc (NASDAQ:GTHX) stock from “an Underweight” to “a Neutral”. The rating was released on January 30, 2023, according to finviz. We previously noted in another research note published on January 03, 2023 by Needham that reiterated the stock to a Buy with a price target […]

Getting Ready for the Bounce: G1 Therapeutics Inc (GTHX) Stock

JP Morgan raised the price target for the G1 Therapeutics Inc (NASDAQ:GTHX) stock from “an Underweight” to “a Neutral”. The rating was released on January 30, 2023, according to finviz. We previously noted in another research note published on January 03, 2023 by Needham that reiterated the stock to a Buy with a price target […]

G1 Therapeutics Inc (GTHX) Stock is Just Right Size-Neither Too Big Nor Too Small

JP Morgan raised the price target for the G1 Therapeutics Inc (NASDAQ:GTHX) stock from “an Underweight” to “a Neutral”. The rating was released on January 30, 2023, according to finviz. We previously noted in another research note published on January 03, 2023 by Needham that reiterated the stock to a Buy with a price target […]

Will Earnings Beat Estimates? G1 Therapeutics Inc (GTHX) Stock

JP Morgan raised the price target for the G1 Therapeutics Inc (NASDAQ:GTHX) stock from “an Underweight” to “a Neutral”. The rating was released on January 30, 2023, according to finviz. We previously noted in another research note published on January 03, 2023 by Needham that reiterated the stock to a Buy with a price target […]

Hold on to your shares: G1 Therapeutics Inc (GTHX) Stock

JP Morgan raised the price target for the G1 Therapeutics Inc (NASDAQ:GTHX) stock from “an Underweight” to “a Neutral”. The rating was released on January 30, 2023, according to finviz. We previously noted in another research note published on January 03, 2023 by Needham that reiterated the stock to a Buy with a price target […]

G1 Therapeutics Inc (NASDAQ:GTHX) Stock upgraded by JP Morgan

JP Morgan raised the price target for the G1 Therapeutics Inc (NASDAQ:GTHX) stock from “an Underweight” to “a Neutral”. The rating was released on January 30, 2023, according to finviz. Historical Earnings Surprises and Revenue Forecasts Profit is the most critical financial performance measure. Every investor in a business is looking forward to the earnings […]

With upside potential, G1 Therapeutics Inc (GTHX) Stock is well-positioned to grow

JP Morgan raised the price target for the G1 Therapeutics Inc (NASDAQ:GTHX) stock from “an Underweight” to “a Neutral”. The rating was released on January 30, 2023, according to finviz. Historical Earnings Surprises and Revenue Forecasts Profit is the most critical financial performance measure. Every investor in a business is looking forward to the earnings […]